Please assess the completion status of the following clinical trial:

Trial Title: Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 or over~* Written informed consent~* Willingness to attend follow-up visits~* Central serous chorioretinopathy affecting visual acuity~* Macular edema from branch retinal vein occlusion~* Macular edema from diabetic microangiopathy~* Age-related macular degeneration with confluent soft drusen~* Age-related macular degeneration with geographic atrophy~Exclusion Criteria~* Macular ischemia~* Retinal hemorrhage impeding retinal laser treatment~* Subretinal neovascular membrane~* Vitreous hemorrhage~* Allergy to fluorescein~* Participation in other clinical trials

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Patients receive selective retinal pigment epithelium laser treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).